NervGen to Advance NVG-291 as Potential Remyelination Therapy for MS
NervGen wants to advance the development of NVG-291, its lead investigational therapy for spinal cord damage, as a…
Ana is a molecular biologist with a passion for communication and discovery. As a science writer, her goal is to provide readers, in particular patients and healthcare providers, with clear and quality information about the latest medical advances. Ana holds a Ph.D. in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in infectious diseases, epigenetics, and gene expression.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
NervGen wants to advance the development of NVG-291, its lead investigational therapy for spinal cord damage, as a…
While neurologists favor Novartis‘ Mayzent (siponimod) for people with active secondary progressive multiple sclerosis (SPMS) and transitioning…
One year of a vegetable-rich diet — combined with exercise, neuromuscular stimulation, and stress reduction techniques — is effective in…
The U.S. Food and Drug Administration (FDA) has approved the use of Botox (onabotulinumtoxinA), marketed by…
As part of National Dysphagia Awareness Month this June, Bracco Diagnostics is acknowledging speech language pathologists for their support in developing…
Obesity, altered lipid (fat) levels, and elevated leptin — an hormone produced by fat cells — may contribute to neuroinflammation,…
A study found no genetic risk factors associated with vitamin D in families with a history of multiple sclerosis…
AxoSim has acquired exclusive rights to lab-grown brain miniatures, coined “Mini-Brain,” a technology developed at Johns Hopkins…
Cyxone submitted an application to the Netherlands research ethics committee to start the first clinical trial…
MC10 and AbbVie are working together to launch clinical trials exploring the use of BioStamp…
Stress-induced changes in gut bacteria, or gut microbiota, may play a significant part in the possible link between…
Vesicles in the blood that contain a protein called fibrinogen important for blood clotting were found to be “sufficient and…
Out-of-pocket costs for medications treating neurological diseases have skyrocketed over the last 12 years in the U.S., with …
Patients with relapsing-remitting multiple sclerosis (RRMS) who switched to infusions with…
Oral treatment with ozanimod (RPC1063), an investigational immunomodulator under development by…
Quanterix is leading the research presented at this year’s American Academy of Neurology (AAN) Annual Meeting, validating the…
Researchers have developed a compound based on the thyroid hormone T3 that is able to repair damaged…
The U.S. Drug Enforcement Administration (DEA) has determined that the cannabidiol…
A pilot study has been launched to assess the immediate and enduring benefits of tai chi and mindfulness meditation on the physical balance and mental wellness of people with multiple sclerosis (MS). This community-based study — currently enrolling participants — is being conducted by the Motor Control Lab directed by Richard van Emmerik, PhD, professor of kinesiology at the University of Massachusetts Amherst. The project was awarded a $54,972 one-year grant from the National Multiple Sclerosis Society. While many MS symptoms vary from patient to patient, depending on the extent and location of the damage in the brain and spinal cord, difficulty in maintaining physical balance is a generalized complaint. Several MS symptoms can have an effect on balance, including difficulties with coordination, tremor and muscle weakness, stiffness, or dizziness and vertigo. "Mind-body interventions are beneficial as they train dynamic balance, such as transitioning between postures, turning, reaching, etc., in a manner similar to movements in daily life," Julianna Averill, a doctoral student at van Emmerik’s lab, said in a press release. Postural control and balance confidence is crucial to prevent patients' falls and reduce their fear of falling. Finding strategies that help patients cope and overcome this limitation is crucial, Averill noted. Contrary to other studies, which focus on mental health benefits, this project will look mostly at the effects of mindfulness practice on physical balance. Tai chi also will be evaluated for its potential to improve patients’ balance, both while they are standing and as they move. Participants will be randomly assigned to either eight weeks of free tai chi at YMAA Western Mass Tai Chi or mindfulness meditation classes at Downtown Mindfulness, in Hampshire County, Massachusetts. Tai chi is a Chinese martial art that involves body stretching and slow, focused, flowing postures that keep the body in motion. Mindfulness meditation is based on mindfulness practices, including training on body scan meditation, and loving kindness meditation. Participants will attend classes for 2.5 hours per week, where they will receive training to complete an additional 2.5 hours at home each week. At home, participants are asked to listen to meditation podcasts, or watch tai chi videos via a website that also tracks their activity. “The participants will be trained, and they will be able to practice on their own,” Averill said. Patients' postural sway will be recorded by wearable sensors while performing distinct movements at the study start, at the end of all classes, and two weeks later. On the same visits, participants will be surveyed to assess the frequency of falls, balance confidence, level of fatigue, and ability to cope and adapt. “We’re taking a more holistic look, considering the whole person and overall quality of life,” Averill said. The team plans to enroll 30 participants with mild-to-moderate MS symptoms, aged 21 to 70, and who are able to stand and move without assistance for 15 minutes. For more information about the study and how to participate, contact Averill at [email protected].
Nearly 18% of new multiple sclerosis (MS) patients referred to…
A woman’s age at her first menstruation, or becoming pregnant and breastfeeding does not substantially influence the long-term…
A product called acrolein, which is naturally excreted by the body and possible to measure in urine and blood, may…
Treatment with Ampyra (dalfampridine) for 24 weeks leads to sustained and clinically meaningful improvements in walking ability as reported…
Multiple sclerosis (MS) patients who have been relapse-free while using an interferon-beta (IFN-β) therapy but switch to another IFN-β are…
Lipoic acid (LA), an over-the-counter antioxidant supplement, helps to mildly delay a decline in walking speed in …
A potentially life-threatening case of bleeding in the lungs has been reported and attributed to treatment with Lemtrada (alemtuzumab) by a…
The U.S. Food and Drug Administration (FDA) has issued a safety alert, warning about a rare but life-threatening risk…
Human mesenchymal stem cells (hMSCs), the type of stem cells present in many tissues of adults, may be manipulated to…
Homotaurine, a compound proven safe for humans in long-term clinical trials, has eased autoimmune responses, brain inflammation, and…
The U.S. Food and Drug Administration (FDA) has issued a safety alert, warning that people with relapsing multiple sclerosis (MS) who…
Get regular updates to your inbox.